Last reviewed · How we verify

Chlorhexidine 0.2%, Curasept

University of Oslo · FDA-approved active Small molecule

Chlorhexidine is a broad-spectrum antimicrobial agent that disrupts bacterial cell membranes and denatures proteins, providing antiseptic and disinfectant effects.

Chlorhexidine is a broad-spectrum antimicrobial agent that disrupts bacterial cell membranes and denatures proteins, providing antiseptic and disinfectant effects. Used for Oral antisepsis and plaque control, Prevention of gingivitis and periodontal disease, Oral rinse for antimicrobial purposes.

At a glance

Generic nameChlorhexidine 0.2%, Curasept
SponsorUniversity of Oslo
Drug classAntimicrobial agent / Antiseptic
ModalitySmall molecule
Therapeutic areaOral Health / Dentistry
PhaseFDA-approved

Mechanism of action

Chlorhexidine works by binding to and disrupting the integrity of bacterial cell membranes, leading to leakage of cellular contents and cell death. It also denatures bacterial proteins and interferes with metabolic processes. At the 0.2% concentration in Curasept, it is effective against a wide range of gram-positive and gram-negative bacteria, making it suitable for oral antisepsis and plaque control.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: